Author:
Gomis R.,Espadero R.-M.,Jones R.,Woerle H. J.,Dugi K. A.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference27 articles.
1. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes.;Butler;Diabetes,2003
2. World Health Organization 2009 World Health Organization Media Centre.
3. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49).;Turner;JAMA,1999
4. DPP-4 inhibitors and combined treatment in type 2 diabetes: re-evaluation of clinical success and safety.;de Valk;Rev Diabetic Stud,2007
5. (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors.;Thomas;J Pharmacol Exp Ther,2008
Cited by
151 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献